Evogene 1st-In-Class Model for Generative Molecule Design, Collaboration with Google Cloud

Evogene (NASDAQ: EVGN) has completed version 1.0 of its generative AI foundation model for small molecule design, developed with Google Cloud. The model enhances ChemPass AI's capabilities by simultaneously addressing multiple complex product criteria in pharmaceutical and agricultural applications. The proprietary model achieves 90% precision in novel molecule designs, compared to 29% in traditional GPT AI models, and is built on a dataset of 38 billion molecular structures. The technology enables the creation of potent, synthesizable, and patentable molecules while ensuring strong IP portfolios. Evogene is already developing version 2.0, focusing on enhanced multi-parameter optimization for therapeutic and agricultural applications.

https://www.stocktitan.net/news/EVGN/evogene-announces-completion-of-first-in-class-foundation-model-for-vqpwipp4cwdv.html